Indian Pharmaceutical Industry is richer with the availability of one more beneficial drug, used in the treatment of lung cancer. Tarceva, the name by which the drug is known is produced by the Swiss-pharma company Roche, and will now be available in India
This is certainly a fresh lease of life to nearly 1, 60, 000 lung cancer patients in India. Tarceva has been available in the US since 2004 and in the European Union since 2005. This drug is normally administered to patients with advanced lung cancer, who have not responded well to even one chemotherapy treatment.
AdvertisementTarceva is an established effective treatment for lung cancer, and perhaps the only epidermal growth factor receptor-inhibitor, to offer high survival rates in the treatment of lung cancer
PStone Refuses the Disclosure of the Report in Public One in Ten NHS Dentists Refused To Sign the New Contract M
You May Also Like